<?xml version="1.0" encoding="UTF-8"?>
<p id="Par50">Patients, 18 to 75 years of age, provided written informed consent, and had histologically or cytologically confirmed non-squamous stage IIIB or IV NSCLC according to American Joint Committee on Cancer Staging v6 [
 <xref ref-type="bibr" rid="CR41">41</xref>]; measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v1.0; Eastern Cooperative Oncology Group performance status (ECOG PS) 0 or 1; life expectancy of &gt; 3 months; adequate hematologic, renal, and hepatic function; and use of an effective contraceptive.
</p>
